Dermatology Times

Pediatric AD presents differently across ages. Panelists explore its physical and emotional toll and how targeted therapies are improving quality of life. Watch now: hubs.li/Q047F2Hr0

💡 Mark Lebwohl, MD, discussed how het AdvanceAD-Tx 487-gene expression profile test may help clinicians identify the most appropriate systemic therapy for patients with moderate to severe atopic dermatitis earlier in the treatment journey. hubs.li/Q047B0Hm0 #DermTwitter

📰 Women in Mohs surgery are rising (6%→25% leaders; trainee parity), yet gaps persist in pay, case volume, and visibility. Mentorship, sponsorship, and systemic reforms are key to advancing equity and leadership representation. hubs.li/Q047yGs60 #DermTwitter

☎️▶️ Jessica DeLuise, PA-C, MHS, CCMS, highlights food-as-medicine, faster referrals, and cautious supplement use in conversation with Renata Block, DMSc, MMS, PA-C. hubs.li/Q047yHxc0 #DermDispatch #DermTwitter

📚 In this week's edition of the Journal Digest, we review the latest dermatology research including insights on chronic hand eczema patch testing, case reporting, microbiome impact, and more. hubs.ly/Q047yxTp0 #JournalDigest #CHE #ChronicHandEczema #DermTwitter

💜 To celebrate #WomensHistoryMonth, we asked our experts to share some women who have had the most impact on their life and their careers in dermatology. Lisa Swanson, MD, FAAD, gave a shoutout to her childhood dermatologist, Leslie Knope, and Betty White. #DermTwitter

📈 Occupational UV exposure shows a complex link to #melanoma: outdoor work may not raise overall risk but is tied to higher rates on chronically exposed sites (head/neck), highlighting subtype- and site-specific risk. hubs.li/Q047l07z0 #SkinCancer #DermTwitter

💡 The 487-gene AdvanceAD-Tx GEP test helps predict which atopic dermatitis patients will respond to biologics vs need JAK inhibitors—potentially speeding effective treatment and reducing trial-and-error care. hubs.li/Q047kYRM0 #AtopicDerm #AD #GEP #DermTwitter

📚 In a new study, adding topical #ivermectin 1% cream to KTP 532 nm laser therapy improved facial erythema and significantly reduced inflammatory lesions in #rosacea vs laser alone, with good safety. hubs.li/Q047jBB50 #DermTwitter

📰 Douglas DiRuggiero, DMSc, MHS, PA-C, highlighted nonsteroidal topicals as key options for atopic dermatitis, offering itch relief, barrier support, and durable control across ages. #HorizonsInAdvancedPractice hubs.li/Q047jWZh0 #AtopicDerm #AD #DermTwitter

🚨 The FDA has approved Johnson & Johnson's #icotrokinra (Icotyde), a first-in-class oral IL-23 inhibitor for moderate to severe plaque psoriasis. hubs.li/Q047jF060 #PlaquePsoriasis #DermTwitter

💜 To celebrate Women's History Month, we asked our experts to share some women who have had the most impact on their life and their careers in dermatology. Anthony Rossi, MD, FAAD, FACMS, gave a shoutout to his mom and sister. #WomensHistoryMonth #DermTwitter

Sponsored by Incyte March 31 is the final day to apply for the @Incyte Ingenuity Awards in HS™. At Incyte, we’re devoted to honoring those who make a difference for people with HS. Apply now: hubs.li/Q047fbQH0 #ad © 2025, Incyte. MAT-INC-03097 12/25

📚 A multicenter study found 5-aminolevulinic acid photodynamic therapy achieved ~97% complete response and low recurrence in Bowen’s disease, with excellent cosmetic outcomes. hubs.li/Q0475Gcs0 #DermTwitter #BowensDisease #ALAPDT

📚 A split-face study in patients with skin of color found a multi-targeted dermocosmetic reduced #acne vulgaris lesions by ~45% and improved acne-induced hyperpigmentation intensity by 38% in 57 days. hubs.li/Q0475RDh0 #DermTwitter

📰 For dermatology, 2026 marks a shift from supportive care toward therapies that target the molecular root cause, from gene delivery approaches in epidermolysis bullosa to pathway-directed small molecules in porphyria and mast cell disease. hubs.li/Q0475S4Y0 #DermTwitter

📈 Phase 3 ADorable-1 results show #lebrikizumab significantly improved skin clearance and itch in 363 infants and children with #AD, supporting potential regulatory expansion for pediatric patients. hubs.li/Q0475RKv0 #AtopicDerm #PediatricDerm #DermTwitter

💜🙋‍♀️ To celebrate Women's History Month, we asked our experts to share some women that have had the most impact on their life and their career in dermatology. Harrison Nguyen, MD, MBA, MPH, FAAD, gave a shoutout to his mom and fiancée. #WomensHistoryMonth #DermTwitter

New approaches to prurigo nodularis are changing the treatment landscape. Learn how emerging biologic therapies are opening new possibilities for patients. Watch now: hubs.li/Q0470Cms0

🗓💊 This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more. hubs.li/Q046Vf_t0 #TheRxRecap #DermTwitter